Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer,
2022,
Karolina Buszka ,
Aliki Ntzifa ,
Barbara Owecka ,
Paula Kamińska ,
Agata Kolecka-Bednarczyk ,
Maciej Zabel ,
Michał Nowicki ,
Evi Lianidou ,
Joanna Budna-Tukan ,
Cells, Vol. 11, 1--28, eISSN: 2073-4409,
bibliogr.
summ.
Słowa kluczowe: cell-free DNA (cfDNA), circulating tumor cells (CTCs), exosomes, liquid biopsy, non-small cell lung cancer (NSCLC), tumor-educated platelets (TEPs), tyrosine kinase inhibitors (TKIs)
Kod: CZR-N-WYKAZ
BibTeX
(pkt. 140)
DOI: 10.3390/cells11182871